20.70 USD
▼-0.06-0.29%
盘后 20.35 -1.69%
2026-11-19
市值
$199.73M
市盈率
—
EPS
-1.99
股息率
—
52 周区间
17.40 – 123.75
成交量
110.36K
Beta
0.20
目标价
107.47
52W 低 17.4052W 高 123.75
价格走势
公司简介
Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio includes 5-HT2 Receptors, which are serotonin agonists for epilepsy and neuropsychiatric disorders; and BMB-101, which has completed phase 1 trial for undisclosed seizure disorder and is in phase 2 clinical trials for the developmental and epileptic encephalopathies and absence epilepsies. The company also develops BMB-201 and BMB-202 for the treatment of neurop...